Dow Up 0.76% Nasdaq Up 0.69%

Intercept Pharmaceuticals, Inc. (ICPT)

-NasdaqGS
237.65 Up 8.16(3.56%) Oct 24, 3:59PM EDT
|After Hours : 237.68 Up 0.03 (0.01%) Oct 24, 4:43PM EDT
Prev Close:229.49
Open:230.36
Bid:223.00 x 100
Ask:243.00 x 100
1y Target Est:473.43
Beta:-4.55
Earnings Date:Nov 12 - Nov 17 (Est.)
Day's Range:227.99 - 244.00
52wk Range:46.81 - 497.00
Volume:354,537
Avg Vol (3m):479,254
Market Cap:5.04B
P/E (ttm):N/A
EPS (ttm):-12.99
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ICPTUp 3.56%5.04B
AZNUp 1.11%88.56B
SLXPUp 3.59%8.94B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2,930.32
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-13.15
Quarterly EPS Est (Sep-14) :-1.10
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):4.29

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Intercept Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat chronic liver and intestinal diseases utilizing its proprietary bile acid chemistry. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback